Maravai LifeSciences Holdings, Inc. announced the appointment of Rajesh “Raj” Asarpota as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. Mr. Asarpota will succeed Kevin Herde, who is transitioning to an advisory role to support an effective transition.
Mr. Asarpota brings nearly three decades of executive leadership experience, including over 10 years as CFO of both public and private life sciences and medical device companies. His proven track record includes driving performance, advancing strategic initiatives, and scaling operations through organic growth and strategic acquisitions.
In his new role, Mr. Asarpota will lead Maravai’s global Finance, Accounting, Treasury, Investor Relations, Corporate Strategy, and Information Technology teams. This appointment reinforces the strategic direction set by the Board and strengthens the leadership team, focusing on driving growth and profitability while supporting continued investments in key technologies.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.